Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Teicoplanin on a Three-weekly Administration in the Complex Outpatient Macroactivity Regimen of Infectious Diseases Unit in the Alessandro Manzoni Hospital (Lecco, Italy)

NCT06426212 is registered in ClinicalTrials.gov with Azienda Ospedaliera di Lecco as lead sponsor.

NCT NCT06426212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06426212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Teicoplanin on a Three-weekly Administration in the Complex Outpatient Macroactivity Regimen of Infectious Diseases Unit in the Alessandro Manzoni Hospital (Lecco, Italy)
Lead sponsor
Azienda Ospedaliera di Lecco
Phase
Observational
Overall status
Unknown status
Start date
May 7, 2024
Completion date
June 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

comparison of teicoplanin used three times a week in dsis vs ndiss